189 related articles for article (PubMed ID: 32351060)
21. Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study.
Ostardo E; Impellizzeri D; Cervigni M; Porru D; Sommariva M; Cordaro M; Siracusa R; Fusco R; Gugliandolo E; Crupi R; Schievano C; Inferrera A; Di Paola R; Cuzzocrea S;
Pharmacol Res; 2018 Aug; 134():16-30. PubMed ID: 29800607
[TBL] [Abstract][Full Text] [Related]
22. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
[TBL] [Abstract][Full Text] [Related]
23.
Li W; Yang F; Zhan H; Liu B; Cai J; Luo Y; Zhou X
Evid Based Complement Alternat Med; 2020; 2020():9026901. PubMed ID: 33133219
[TBL] [Abstract][Full Text] [Related]
24. Bruton tyrosine kinase (BTK) may be a potential therapeutic target for interstitial cystitis/bladder pain syndrome.
Wang G; Yang TX; Li JM; Huang ZY; Yang WB; Li P; He DL
Aging (Albany NY); 2022 Sep; 14(17):7052-7064. PubMed ID: 36069808
[TBL] [Abstract][Full Text] [Related]
25. Urinary nerve growth factor correlates with the severity of urgency and pain.
Kim SW; Im YJ; Choi HC; Kang HJ; Kim JY; Kim JH
Int Urogynecol J; 2014 Nov; 25(11):1561-7. PubMed ID: 24866276
[TBL] [Abstract][Full Text] [Related]
26. Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion.
Kim A; Han JY; Ryu CM; Yu HY; Lee S; Kim Y; Jeong SU; Cho YM; Shin DM; Choo MS
Histopathology; 2017 Sep; 71(3):415-424. PubMed ID: 28394416
[TBL] [Abstract][Full Text] [Related]
27. An Immunogenic Peptide, T2 Induces Interstitial Cystitis/Painful Bladder Syndrome: an Autoimmune Mouse Model for Interstitial Cystitis/Painful Bladder Syndrome.
Zhang L; Ihsan AU; Cao Y; Khan FU; Cheng Y; Han L; Zhou X
Inflammation; 2017 Dec; 40(6):2033-2041. PubMed ID: 28799018
[TBL] [Abstract][Full Text] [Related]
28. Digital quantitative analysis of mast cell infiltration in interstitial cystitis.
Akiyama Y; Maeda D; Morikawa T; Niimi A; Nomiya A; Yamada Y; Igawa Y; Goto A; Fukayama M; Homma Y
Neurourol Urodyn; 2018 Feb; 37(2):650-657. PubMed ID: 29065222
[TBL] [Abstract][Full Text] [Related]
29. Potential Urine and Serum Biomarkers in Patients with Bladder Pain Syndrome/Interstitial Cystitis.
Wang L; Gao J; Zheng S; Wang Z; Zheng S; Luo Z
Arch Esp Urol; 2024 May; 77(4):353-358. PubMed ID: 38840277
[TBL] [Abstract][Full Text] [Related]
30. Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome.
Regauer S; Gamper M; Fehr MK; Viereck V
J Urol; 2017 Jan; 197(1):159-166. PubMed ID: 27378135
[TBL] [Abstract][Full Text] [Related]
31. Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis?
Gamper M; Regauer S; Welter J; Eberhard J; Viereck V
J Urol; 2015 Jun; 193(6):1994-2000. PubMed ID: 25596361
[TBL] [Abstract][Full Text] [Related]
32. Serpina3n/serpina3 alleviates cyclophosphamide-induced interstitial cystitis by activating the Wnt/β-catenin signal.
Fang W; Song Q; Lv T; Lv J; Cai Z; Wang Z; Song X; Ji X; Huang J
Int Urol Nephrol; 2023 Dec; 55(12):3065-3075. PubMed ID: 37594700
[TBL] [Abstract][Full Text] [Related]
33. Temporally complex inflammatory networks in an animal model reveal signatures for interstitial cystitis and bladder pain syndrome phenotype.
Shah AM; Vodovotz Y; Yoshimura N; Chermansky CJ; Fitzgerald J; Tyagi P
Neurourol Urodyn; 2023 Nov; 42(8):1839-1848. PubMed ID: 37587846
[TBL] [Abstract][Full Text] [Related]
34. Specific inhibition of ICAM-1 effectively reduces bladder inflammation in a rat model of severe non-bacterial cystitis.
Zhang X; He H; Lu G; Xu T; Qin L; Wang X; Jin X; Liu B; Zhao Z; Shen Z; Shao Y
Sci Rep; 2016 Oct; 6():35672. PubMed ID: 27782122
[TBL] [Abstract][Full Text] [Related]
35. Abnormal Akt signalling in bladder epithelial cell explants from patients with interstitial cystitis/bladder pain syndrome can be induced by antiproliferative factor treatment of normal bladder cells.
Keay SK; Zhang CO
BJU Int; 2016 Jul; 118(1):161-72. PubMed ID: 26919663
[TBL] [Abstract][Full Text] [Related]
36. [Electron microscopic characterization of the mucous membrane of the bladder with interstitial cystitis/painful bladder syndrome in the experiment].
Sholan RF; Gasimov EK
Urologiia; 2020 Sep; (4):14-17. PubMed ID: 32897008
[TBL] [Abstract][Full Text] [Related]
37. MCP-1-induced histamine release from mast cells is associated with development of interstitial cystitis/bladder pain syndrome in rat models.
Lv J; Huang Y; Zhu S; Yang G; Zhang Y; Leng J; Bo J; Liu D
Mediators Inflamm; 2012; 2012():358184. PubMed ID: 23049171
[TBL] [Abstract][Full Text] [Related]
38. Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).
Chuang YC; Chermansky C; Kashyap M; Tyagi P
Expert Opin Investig Drugs; 2016; 25(5):521-9. PubMed ID: 26940379
[TBL] [Abstract][Full Text] [Related]
39. Diffusion-Weighted Magnetic Resonance Imaging: A New Tool for the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis.
Charlanes A; Boudghene F; Chesnel C; Ciofu C; Le Breton F; Jousse M; Amarenco G; Manceau P
Urol Int; 2019; 102(1):109-112. PubMed ID: 30428470
[TBL] [Abstract][Full Text] [Related]
40. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients.
Okragly AJ; Niles AL; Saban R; Schmidt D; Hoffman RL; Warner TF; Moon TD; Uehling DT; Haak-Frendscho M
J Urol; 1999 Feb; 161(2):438-41; discussion 441-2. PubMed ID: 9915421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
